HONG KONG,Jan. 8,2025-- PearlMountain Limited is pleased to announce the latest update to its flagship video creation platform,FlexClip,featuring two powerful new tools: AI Video Generator and Motion
HOI AN,Vietnam,Jan. 6,2025--Hoiana Resort & Golf is delighted to celebrate Lunar New Year 2025 with exclusive "Fun-Tết-Stic" program,running from January 15 to February 28,2025. The pr
LAS VEGAS,Jan. 7,2025--The Greet,a pioneering Korean startup specializing in comprehensive reusable container solutions,is set to make its mark atCES 2025,the world\'s largest IT and consumer electron
AD/ADAS Sensing components,including the RGB-IR In-Cabin Camera Module,in the limelight
Unveiling of new products for automotive communication and lighting,from AP modules to Nexlide Vision
TAIPEI,Jan. 7,2025-- As the future of retail shifts towards an integrated omnichannel ecosystem,it is projected to become a trillion-dollar industry. While many businesses already possess strong produ
NEW YORK,Jan. 7,2025-- Aquaron Acquisition Corp. (NASDAQ: AQU,the "Company"),a special purpose acquisition company,announced today that HUTURE Ltd. ("Huture") has deposited into th
SUZHOU,China,Jan. 7,2025--Suzhou China Star Optoelectronics Technology Co.,Ltd. ("TCL CSOT Suzhou") has joined the Science Based Targets initiative (SBTi),reinforcing its commitment to scien
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
